首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1593510

新生兒篩檢市場規模、佔有率和成長分析（按產品、技術、測試類型和地區）：產業預測（2024-2031）

Newborn Screening Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type (Dry Blood Spot Test, CCHD), By Region - Industry Forecast 2024-2031

出版日期: 2024年11月15日 | 出版商:

SkyQuest | 英文 177 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023年，全球新生兒篩檢市場規模為12.5億美元，從2024年的13.4億美元成長到2031年的21.2億美元，在預測期間（2024-2031年）預計複合年成長率為6.8。。

出生率的上升、嬰幼兒先天性疾病的增加、消費者意識的提高以及政府的支持措施共同為新生兒篩檢產業創造了強勁的成長軌跡。世界衛生組織（WHO）指出，先天性疾病導致約24萬名新生兒在出生後28天內死亡，約17萬名1個月至5歲兒童死亡，強調了情況的嚴重性。具體而言，印度先天性代謝缺陷的盛行率在 2% 至 7.8% 之間，每 1,000 名新生兒中就有 2.1 人患有先天性甲狀腺機能低下症，隨著檢測變得更加廣泛，印度將成為一個巨大的市場。隨著更有效率、更有效的方法的出現，篩檢方法的技術進步進一步推動市場成長。此外，曼尼托巴省於 2022 年 6 月啟動的擴大新生兒篩檢以納入脊髓性肌肉萎縮症的舉措等政府主導的計劃將加強篩檢領域，鼓勵廣泛採用篩檢通訊協定，並在促進實施方面發揮作用。隨著對先天性疾病了解的加深以及早期檢測對社會變得更加重要，預計到 2031 年，新生兒篩檢市場將大幅擴大。這些因素集中為新生兒篩檢的創新和投資創造了有利的環境，使其成為醫療保健相關人員關注的關鍵領域。

北美（按產品、測試、技術、最終用戶）
- 美國
- 加拿大
歐洲（按產品、測試、技術、最終用戶）
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家
亞太地區（依產品、測試、技術、最終用戶）
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲（按產品、測試、技術、最終用戶）
- 巴西
- 其他拉丁美洲
中東/非洲（按產品、測試、技術、最終用戶）
- 波灣合作理事會(GCC) 國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 年比收益成長（YoY）比較（2021-2023）

主要企業簡介

Masimo Corp.
Covidien Plc
AB Sciex LLC
Natus Medical Inc.
Agilent Technologies Inc.
PerkinElmer Inc.
GE Healthcare
Bio-Rad Laboratories Inc.
Trivitron Healthcare
Medtronic Inc.
Rady Children's Institute for Genomic Medicine
GE Lifesciences
Waters Corporation
Danaher Corporation
Thermo Fisher Scientific Inc.
ZIVAK TECHNOLOGIES
CAMAG
OTODYNAMICS
ZENTECH
VIVOSONIC

結論和建議

簡介目錄

Product Code: SQMIG35E2050

Global Newborn Screening Market size was valued at USD 1.25 Billion in 2023 and is poised to grow from USD 1.34 Billion in 2024 to USD 2.12 Billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Market insights reveal a robust growth trajectory for the newborn screening sector, driven by a combination of rising birth rates, increasing congenital illnesses among infants, heightened consumer awareness, and supportive government initiatives. The World Health Organization highlights the gravity of the situation, noting that congenital disorders are responsible for approximately 240,000 neonatal deaths annually within the first 28 days of birth, and around 170,000 child deaths from one month to five years old. Specifically, the prevalence of in-born metabolic disorders in India ranges from 2% to 7.8%, with congenital hypothyroidism affecting 2.1 out of every 1,000 newborns, indicating a significant market potential as testing becomes more prevalent. Technological advancements in screening methodologies are further propelling market growth, as more efficient and effective techniques become available. Additionally, government-led programs, such as Manitoba's initiative launched in June 2022 to expand its newborn screening to include spinal muscular atrophy, serve to enhance the screening landscape, encouraging wider adoption and implementation of screening protocols. As the understanding of congenital disorders deepens and societal emphasis on early detection intensifies, the newborn screening market is expected to see considerable expansion through 2031. The convergence of these elements establishes a favorable climate for innovation and investment in newborn screening, positioning it as a critical area of focus for stakeholders in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Newborn Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Newborn Screening Market Segmental Analysis

Global Newborn Screening Market is segmented by Product, Test, technology, end user and region. Based on Product, the market is segmented into Consumables, Instruments, Hearing screening instruments, Pulse oximeters. Based on Test, the market is segmented into Dry blood spot tests, Hearing screening tests, CCHD screening tests. Based on technology, the market is segmented into Immune assays & enzymatic assays, Tandem mass spectrometry, Molecular assays, Hearing screening technologies, Pulse oximetry, Other Technologies. Based on end user, the market is segmented into Clinical Laboratories, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Newborn Screening Market

The rising prevalence of congenital abnormalities is a key market driver for the Global Newborn Screening market, fueling demand for early diagnostic solutions. Conditions such as genetic disorders, hearing impairments, and metabolic disorders emphasize the need for prompt identification and intervention, which can significantly enhance treatment outcomes and the quality of life for affected neonates. As medical technology advances and understanding of the benefits of early diagnosis deepens, the importance of comprehensive screening programs becomes increasingly evident. Additionally, heightened awareness of congenital disorders and focused initiatives to safeguard newborn health are encouraging the adoption of thorough screening techniques, thus bolstering market growth.

Restraints in the Global Newborn Screening Market

The high cost of newborn screening tests presents a significant market restraint, particularly impacting low- and middle-income countries. These financial barriers restrict access to essential screening, preventing families from benefiting from potentially lifesaving treatments. As a result, the delay in detection and intervention can severely compromise the health outcomes of affected neonates. Furthermore, the existing disparity in access to these critical tests highlights the urgent need for more affordable screening options and support networks that promote equitable early diagnostic services. Addressing this monetary limitation is crucial for advancing global infant health and ensuring all newborns receive adequate care.

Market Trends of the Global Newborn Screening Market

The Global Newborn Screening market is witnessing a significant trend towards advanced genetic testing integration, characterized by the adoption of Whole Genome Sequencing (WGS) and Next-Generation Sequencing (NGS). These innovative technologies facilitate the precise identification of a broader range of genetic disorders, including complex and rare conditions often overlooked by traditional methods. As the costs associated with genetic testing continue to decline, the availability of comprehensive screening panels is expanding, enabling earlier and more accurate detection of genetic abnormalities. This evolution not only enhances the efficacy of newborn screening programs but also improves clinical outcomes, driving demand and growth within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Market Attractiveness Index

Global Newborn Screening Market Size by Product & CAGR (2024-2031)

Market Overview
Consumables
Instruments
Hearing screening instruments
Pulse oximeters

Global Newborn Screening Market Size by Test & CAGR (2024-2031)

Market Overview
Dry blood spot tests
Hearing screening tests
CCHD screening tests

Global Newborn Screening Market Size by Technology & CAGR (2024-2031)

Market Overview
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Other Technologies

Global Newborn Screening Market Size by End User & CAGR (2024-2031)

Market Overview
Clinical Laboratories
Hospitals

Global Newborn Screening Market Size & CAGR (2024-2031)

North America, (Product, Test, Technology, End User)
- US
- Canada
Europe, (Product, Test, Technology, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Test, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Test, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Test, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Masimo Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covidien Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB Sciex LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rady Children's Institute for Genomic Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZIVAK TECHNOLOGIES
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CAMAG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OTODYNAMICS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZENTECH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VIVOSONIC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments